Claris Biotherapeutics announced it raised $44.5 Million in an amended filing from an offering of $44.5 Million

Oct 24, 2023•about 2 years ago

Amount Raised

$44.5 Million

Jersey CityBiotechnology

Company Information

Company

Claris Biotherapeutics

Location

299 PAVONIA AVENUE 3-8

Jersey City, New Jersey, United States

About

Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars. The formulation creates a recombinant hepatocyte growth factor which accelerates the healing process, providing healthcare providers noninvasive therapeutic treatment.

Related People

2 contacts

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Claris Biotherapeutics announced it raised $44.5 Million in an amended filing from an offering of $44.5 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information